ImmuCell Corp (ICCC)
5.04
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 16:00
5.04
0.00 (0.00%)
After-Hours: 20:00
ImmuCell Total Assets (Quarterly): 43.81M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 43.81M |
| September 30, 2023 | 44.54M |
| June 30, 2023 | 44.01M |
| March 31, 2023 | 43.12M |
| December 31, 2022 | 44.86M |
| September 30, 2022 | 46.40M |
| June 30, 2022 | 45.98M |
| March 31, 2022 | 46.70M |
| December 31, 2021 | 44.47M |
| September 30, 2021 | 44.23M |
| June 30, 2021 | 43.73M |
| March 31, 2021 | 39.62M |
| December 31, 2020 | 40.35M |
| September 30, 2020 | 39.99M |
| June 30, 2020 | 40.66M |
| March 31, 2020 | 40.05M |
| December 31, 2019 | 38.69M |
| September 30, 2019 | 38.85M |
| June 30, 2019 | 39.41M |
| March 31, 2019 | 40.48M |
| December 31, 2018 | 32.73M |
| September 30, 2018 | 33.24M |
| June 30, 2018 | 32.74M |
| March 31, 2018 | 33.63M |
| December 31, 2017 | 34.30M |
| Date | Value |
|---|---|
| September 30, 2017 | 30.29M |
| June 30, 2017 | 28.06M |
| March 31, 2017 | 25.33M |
| December 31, 2016 | 24.70M |
| September 30, 2016 | 20.58M |
| June 30, 2016 | 20.57M |
| March 31, 2016 | 20.38M |
| December 31, 2015 | 14.54M |
| September 30, 2015 | 14.22M |
| June 30, 2015 | 11.24M |
| March 31, 2015 | 11.23M |
| December 31, 2014 | 11.05M |
| September 30, 2014 | 10.74M |
| June 30, 2014 | 10.77M |
| March 31, 2014 | 11.12M |
| December 31, 2013 | 10.96M |
| September 30, 2013 | 11.07M |
| June 30, 2013 | 11.37M |
| March 31, 2013 | 11.11M |
| December 31, 2012 | 11.03M |
| September 30, 2012 | 10.97M |
| June 30, 2012 | 11.04M |
| March 31, 2012 | 11.17M |
| December 31, 2011 | 10.99M |
| September 30, 2011 | 10.98M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
38.69M
Minimum
Dec 2019
46.70M
Maximum
Mar 2022
42.60M
Average
43.73M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.82M |
| Shareholders Equity (Quarterly) | 24.99M |
| Debt to Equity Ratio | 0.4789 |
| Current Ratio | 2.733 |
| Net Debt Paydown Yield | -0.76% |